Literature DB >> 10924808

Spared nerve injury: an animal model of persistent peripheral neuropathic pain.

Isabelle Decosterd1, Clifford J Woolf.   

Abstract

Peripheral neuropathic pain is produced by multiple etiological factors that initiate a number of diverse mechanisms operating at different sites and at different times and expressed both within, and across different disease states. Unraveling the mechanisms involved requires laboratory animal models that replicate as far as possible, the different pathophysiological changes present in patients. It is unlikely that a single animal model will include the full range of neuropathic pain mechanisms. A feature of several animal models of peripheral neuropathic pain is partial denervation. In the most frequently used models a mixture of intact and injured fibers is created by loose ligation of either the whole (Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988;33:87-107) or a tight ligation of a part (Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 1990;43:205-218) of a large peripheral nerve, or a tight ligation of an entire spinal segmental nerve (Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992;50:355-363). We have developed a variant of partial denervation, the spared nerve injury model. This involves a lesion of two of the three terminal branches of the sciatic nerve (tibial and common peroneal nerves) leaving the remaining sural nerve intact. The spared nerve injury model differs from the Chung spinal segmental nerve, the Bennett chronic constriction injury and the Seltzer partial sciatic nerve injury models in that the co-mingling of distal intact axons with degenerating axons is restricted, and it permits behavioral testing of the non-injured skin territories adjacent to the denervated areas. The spared nerve injury model results in early (<24 h), prolonged (>6 months), robust (all animals are responders) behavioral modifications. The mechanical (von Frey and pinprick) sensitivity and thermal (hot and cold) responsiveness is increased in the ipsilateral sural and to a lesser extent saphenous territories, without any change in heat thermal thresholds. Crush injury of the tibial and common peroneal nerves produce similar early changes, which return, however to baseline at 7-9 weeks. The spared nerve injury model may provide, therefore, an additional resource for unraveling the mechanisms responsible for the production of neuropathic pain.

Entities:  

Mesh:

Year:  2000        PMID: 10924808     DOI: 10.1016/S0304-3959(00)00276-1

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  671 in total

1.  Coding of facial expressions of pain in the laboratory mouse.

Authors:  Dale J Langford; Andrea L Bailey; Mona Lisa Chanda; Sarah E Clarke; Tanya E Drummond; Stephanie Echols; Sarah Glick; Joelle Ingrao; Tammy Klassen-Ross; Michael L Lacroix-Fralish; Lynn Matsumiya; Robert E Sorge; Susana G Sotocinal; John M Tabaka; David Wong; Arn M J M van den Maagdenberg; Michel D Ferrari; Kenneth D Craig; Jeffrey S Mogil
Journal:  Nat Methods       Date:  2010-05-09       Impact factor: 28.547

2.  Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice.

Authors:  Molly S Crowe; Emma Leishman; Matthew L Banks; Ramesh Gujjar; Anu Mahadevan; Heather B Bradshaw; Steven G Kinsey
Journal:  Br J Pharmacol       Date:  2015-01-20       Impact factor: 8.739

3.  Sciatic nerve injury in adult rats causes distinct changes in the central projections of sensory neurons expressing different glial cell line-derived neurotrophic factor family receptors.

Authors:  Janet R Keast; Shelley L Forrest; Peregrine B Osborne
Journal:  J Comp Neurol       Date:  2010-08-01       Impact factor: 3.215

4.  A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats.

Authors:  Jing Wang; Yossef Goffer; Duo Xu; David S Tukey; D B Shamir; Sarah E Eberle; Anthony H Zou; Thomas J J Blanck; Edward B Ziff
Journal:  Anesthesiology       Date:  2011-10       Impact factor: 7.892

5.  Neuropathic Pain Creates an Enduring Prefrontal Cortex Dysfunction Corrected by the Type II Diabetic Drug Metformin But Not by Gabapentin.

Authors:  Stephanie Shiers; Grishma Pradhan; Juliet Mwirigi; Galo Mejia; Ayesha Ahmad; Sven Kroener; Theodore Price
Journal:  J Neurosci       Date:  2018-07-20       Impact factor: 6.167

6.  Intrathecal AAV serotype 9-mediated delivery of shRNA against TRPV1 attenuates thermal hyperalgesia in a mouse model of peripheral nerve injury.

Authors:  Takashi Hirai; Mitsuhiro Enomoto; Hidetoshi Kaburagi; Shinichi Sotome; Kie Yoshida-Tanaka; Madoka Ukegawa; Hiroya Kuwahara; Mariko Yamamoto; Mio Tajiri; Haruka Miyata; Yukihiko Hirai; Makoto Tominaga; Kenichi Shinomiya; Hidehiro Mizusawa; Atsushi Okawa; Takanori Yokota
Journal:  Mol Ther       Date:  2013-10-28       Impact factor: 11.454

7.  Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain.

Authors:  Victoria C J Wallace; Julie Blackbeard; Andrew R Segerdahl; Fauzia Hasnie; Timothy Pheby; Stephen B McMahon; Andrew S C Rice
Journal:  Brain       Date:  2007-08-30       Impact factor: 13.501

8.  Calcium-permeable AMPA receptors in the nucleus accumbens regulate depression-like behaviors in the chronic neuropathic pain state.

Authors:  Yossef Goffer; Duo Xu; Sarah E Eberle; James D'amour; Michelle Lee; David Tukey; Robert C Froemke; Edward B Ziff; Jing Wang
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

9.  The prostaglandin E2 receptor EP3 controls CC-chemokine ligand 2-mediated neuropathic pain induced by mechanical nerve damage.

Authors:  Elsa-Marie Treutlein; Katharina Kern; Andreas Weigert; Neda Tarighi; Claus-Dieter Schuh; Rolf M Nüsing; Yannick Schreiber; Nerea Ferreirós; Bernhard Brüne; Gerd Geisslinger; Sandra Pierre; Klaus Scholich
Journal:  J Biol Chem       Date:  2018-05-11       Impact factor: 5.157

10.  Runx1 controls terminal morphology and mechanosensitivity of VGLUT3-expressing C-mechanoreceptors.

Authors:  Shan Lou; Bo Duan; Linh Vong; Bradford B Lowell; Qiufu Ma
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.